Company
Captor Therapeutics
- Biotech
- Headquarters:
- Wrocław
Description
Captor Therapeutics builds targeted protein degradation therapeutics and drug discovery platforms to develop degrader medicines for cancer and autoimmune disease patients, serving biopharmaceutical development and clinical research customers.
Related
Bristol Myers Squibb (San Diego)Bristol Myers Squibb (San Diego) develops medicines through biopharmaceutical research, clinical trials, and product development, providing…
Neumora TherapeuticsNeumora Therapeutics develops precision neuroscience medicines by combining drug discovery, data science, and clinical development to…
Xaira TherapeuticsXaira Therapeutics builds an AI-powered drug discovery and development platform to decode disease, design therapies, and support end-to-end…
Ability PharmaceuticalsAbilityPharma develops biopharmaceutical drug candidates. Its clinical pipeline targets cancer treatment, including ABTL0812 trials for…
Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague)IOCB Prague conducts scientific research connected to drug discovery and development; its work includes protein research, publications, and…
Leibniz-Institut für Immuntherapie (LIT)The institute develops immune cell therapies for cancer, autoimmune disease, and chronic inflammation, spanning discovery research,…
NucleraNuclera builds and supplies eProtein Discovery systems, cartridges, reagents and services for multiplex cell-free protein screening used by…
BrainEverBrainEver develops homeoprotein-based biopharmaceutical therapies to halt neurodegenerative disease progression, producing drug candidates…
BIMINI BiotechBIMINI Biotech develops first-in-class small-molecule therapeutics modulating the Wiskott–Aldrich Syndrome protein for oncology and…
Sana Biotechnology ($SANA)Sana Biotechnology builds engineered cell medicines that repair or control genes, or replace damaged cells, for patients with diseases…
Kyverna Therapeutics (San Diego)Kyverna Therapeutics (San Diego) develops cell therapies for autoimmune disease patients, including an autologous CD19-targeting CAR T…
Mammoth BiosciencesMammoth Biosciences develops in vivo CRISPR-based gene editing therapeutics and supporting protein discovery tools for use in genetic…